Provided by Tiger Fintech (Singapore) Pte. Ltd.

Madrigal Pharmaceuticals

283.04
+3.441.23%
Volume:182.75K
Turnover:51.73M
Market Cap:6.28B
PE:-15.75
High:287.27
Open:281.03
Low:275.00
Close:279.60
Loading ...

Madrigal Pharmaceuticals Q1 EPS $(3.32) Beats $(3.61) Estimate, Sales $137.25M Beat $113.76M Estimate

Benzinga
·
01 May

BRIEF-Madrigal Pharmaceuticals Q1 EPS USD -3.32

Reuters
·
01 May

Madrigal Pharmaceuticals Reports First-Quarter 2025 Financial Results and Provides Corporate Updates

THOMSON REUTERS
·
01 May

Madrigal Pharmaceuticals Q1 Operating Income USD -79.311 Million

THOMSON REUTERS
·
01 May

Madrigal Pharmaceuticals Q1 EPS USD -3.32

THOMSON REUTERS
·
01 May

Madrigal Pharmaceuticals Q1 Operating Expenses USD 216.561 Million

THOMSON REUTERS
·
01 May

Madrigal Pharmaceuticals Inc: First-Quarter 2025 Net Revenues of $137.3 Million

THOMSON REUTERS
·
01 May

Madrigal Pharmaceuticals announces six presentations at EASL Congress

TIPRANKS
·
29 Apr

Madrigal to Present Late-Breaking Resmetirom Data in Patients with Compensated MASH Cirrhosis at the EASL Congress

GlobeNewswire
·
29 Apr

Exploring High Growth Tech Stocks in the US Market

Simply Wall St.
·
29 Apr

Madrigal Pharmaceuticals Price Target Maintained With a $443.00/Share by JMP Securities

Dow Jones
·
24 Apr

Madrigal Pharmaceuticals to Release First-Quarter 2025 Financial Results and Host Webcast on May 1, 2025

GlobeNewswire
·
18 Apr

Madrigal Pharmaceuticals Announces Leadership Transition

TIPRANKS
·
18 Apr

BRIEF-Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.D. To Become Senior Scientific And Medical Advisor David Soergel, M.D., Appointed Chief Medical Officer

Reuters
·
16 Apr

Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.d. to Become Senior Scientific and Medical Advisor; David Soergel, M.d., Appointed Chief Medical Officer

THOMSON REUTERS
·
16 Apr

Is Madrigal Pharmaceuticals (MDGL) The Most Expensive Stock Insiders Are Dumping In March?

Insider Monkey
·
29 Mar

Exploring 3 High Growth Tech Stocks in the US Market

Simply Wall St.
·
29 Mar

Analysts Expect Breakeven For Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Before Long

Simply Wall St.
·
26 Mar

Madrigal Pharmaceuticals (MDGL): Among the Best Biotech Stocks to Buy According to Billionaires

Insider Monkey
·
18 Mar

Madrigal Pharmaceuticals appoints Fouse to its board of directors

TIPRANKS
·
11 Mar